Catalent and Novo Holdings Receive European Commission Unconditional Approval for Pending Transaction
Catalent, Inc. (Catalent, NYSE: CTLT), a leader in enabling the development and supply of better treatments for patients worldwide, and Novo Holdings A/S (Novo Holdings), a global life sciences...